In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide
Author(s) -
Raquel Villar,
Esther Vicente,
Beatriz Solano,
Silvia PérezSilanes,
Ignacio Aldana,
Joseph A. Maddry,
Anne J. Lenaerts,
Scott G. Franzblau,
SangHyun Cho,
Antonio Monge,
Robert C. Goldman
Publication year - 2008
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkn214
Subject(s) - mycobacterium tuberculosis , in vivo , microbiology and biotechnology , isoniazid , pharmacology , quinoxaline , antimycobacterial , chemistry , tuberculosis , active metabolite , in vitro , drug resistance , medicine , biology , pharmacokinetics , biochemistry , organic chemistry , pathology
To evaluate a novel series of quinoxaline 1,4-di-N-oxides for in vitro activity against Mycobacterium tuberculosis and for efficacy in a mouse model of tuberculosis (TB).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom